Hypertension and atrial fibrillation: Closing a virtuous circle
- PMID: 34061832
- PMCID: PMC8168876
- DOI: 10.1371/journal.pmed.1003598
Hypertension and atrial fibrillation: Closing a virtuous circle
Abstract
Ying Gue and Gregory Lip discuss the accompanying study by Ana-Catarina Pinho-Gomes and co-workers on blood pressure lowering treatment in patients with atrial fibrillation.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: GYHL has served as a consultant for Bayer/Janssen, Bristol-Meyers Squibb/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon, and Daiichi Sankyo. He has been a speaker for Bayer, Bristol-Meyers Squibb/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, and Medtronic. No fees are personally received. YXG has no financial disclosures.
Comment on
-
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.PLoS Med. 2021 Jun 1;18(6):e1003599. doi: 10.1371/journal.pmed.1003599. eCollection 2021 Jun. PLoS Med. 2021. PMID: 34061831 Free PMC article.
References
-
- Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S, et al.. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ’Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension. J Hypertens. 2012;30(2):239–52. 10.1097/HJH.0b013e32834f03bf - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical